Cargando…

The clinical outcome of pazopanib treatment in Japanese patients with relapsed soft tissue sarcoma: A Japanese Musculoskeletal Oncology Group (JMOG) study

BACKGROUND: Because the efficacy and safety of pazopanib in Japanese patients with soft tissue sarcoma (STS) had not been evaluated previously in a large‐scale cohort, the authors investigated the efficacy and safety of pazopanib in 156 Japanese patients with relapsed STS. This was a retrospective s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakamura, Tomoki, Matsumine, Akihiko, Kawai, Akira, Araki, Nobuhito, Goto, Takahiro, Yonemoto, Tsukasa, Sugiura, Hideshi, Nishida, Yoshihiro, Hiraga, Hiroaki, Honoki, Kanya, Yasuda, Taketoshi, Boku, Shogen, Sudo, Akihiro, Ueda, Takafumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069581/ https://www.ncbi.nlm.nih.gov/pubmed/26970174 http://dx.doi.org/10.1002/cncr.29961

Ejemplares similares

A randomized, double-blind, placebo-controlled, Phase III study of pazopanib in patients with soft tissue sarcoma: results from the Japanese subgroup
por: Kawai, Akira, et al.
Publicado: (2016)

Factors that Influence Functional Outcome after Total or Subtotal Scapulectomy: Japanese Musculoskeletal Oncology Group (JMOG) Study
por: Hayashi, Katsuhiro, et al.
Publicado: (2014)

Efficacy of Trabectedin in Patients with Advanced Translocation‐Related Sarcomas: Pooled Analysis of Two Phase II Studies
por: Takahashi, Mitsuru, et al.
Publicado: (2017)

Perivascular epithelioid cell tumors (PEComas) of the bone and soft tissue: a Japanese Musculoskeletal Oncology Group (JMOG) multi-institutional study
por: Izubuchi, Yuya, et al.
Publicado: (2023)

Time lapse analysis of tumor response in patients with soft tissue sarcoma treated with trabectedin: A pooled analysis of two phase II clinical trials
por: Endo, Makoto, et al.
Publicado: (2020)

Results of sub-analysis of a phase 2 study on trabectedin treatment for extraskeletal myxoid chondrosarcoma and mesenchymal chondrosarcoma
por: Morioka, Hideo, et al.
Publicado: (2016)

Phase II trial of pazopanib in patients with metastatic or unresectable chemoresistant sarcomas: A Japanese Musculoskeletal Oncology Group study
por: Urakawa, Hiroshi, et al.
Publicado: (2020)

Systemic Therapy for Soft Tissue Sarcoma: Proposals for the Optimal Use of Pazopanib, Trabectedin, and Eribulin
por: Kawai, Akira, et al.
Publicado: (2017)

Deep infection in tumor endoprosthesis around the knee: a multi-institutional study by the Japanese musculoskeletal oncology group
por: Morii, Takeshi, et al.
Publicado: (2013)

Phase 2 study of eribulin in patients with previously treated advanced or metastatic soft tissue sarcoma(†)
por: Kawai, Akira, et al.
Publicado: (2017)

Clinical outcome of recurrent giant cell tumor of the extremity in the era before molecular target therapy: the Japanese Musculoskeletal Oncology Group study
por: Takeuchi, Akihiko, et al.
Publicado: (2016)

Phase I and pharmacokinetic study of trabectedin, a DNA minor groove binder, administered as a 24-h continuous infusion in Japanese patients with soft tissue sarcoma
por: Ueda, Takafumi, et al.
Publicado: (2014)

4-step, 2-h carboplatin desensitization in Japanese patients with ovarian cancer: a prospective study
por: Nishimura, Meiko, et al.
Publicado: (2021)

Standard Treatment Remains the Recommended Approach for Patients with Bone Sarcoma Who Underwent Unplanned Surgery: Report from the Japanese Musculoskeletal Oncology Group
por: Nakamura, Tomoki, et al.
Publicado: (2020)

Oncological outcome after lung metastasis in patients presenting with localized chondrosarcoma at extremities: Tokai Musculoskeletal Oncology Consortium study
por: Nakamura, Tomoki, et al.
Publicado: (2016)

Physical Function of Japanese Preadolescents during the COVID-19 Pandemic
por: Narahara, Sho, et al.
Publicado: (2022)

Association between pazopanib exposure and safety in Japanese patients with renal cell carcinoma or soft tissue sarcoma
por: Aoyama, Takeshi, et al.
Publicado: (2023)

Preventing aging with stem cell rejuvenation: Feasible or infeasible?
por: Honoki, Kanya
Publicado: (2017)

Long-Term Results of Kyocera Modular Limb Salvage System after Resection of Tumors in the Distal Part of the Femur: Report from Japanese Musculoskeletal Oncology Group Study
por: Nakamura, Tomoki, et al.
Publicado: (2022)

Season of birth effect on psychotic-like experiences in Japanese adolescents
por: Tochigi, Mamoru, et al.
Publicado: (2012)

Relationship between the skeletal muscle mass index and physical activity of Japanese children: A cross-sectional, observational study
por: Ito, Tadashi, et al.
Publicado: (2021)

Three-dimensional gait analysis of lower extremity gait parameters in Japanese children aged 6 to 12 years
por: Ito, Tadashi, et al.
Publicado: (2022)

The value of trabectedin in the treatment of soft tissue sarcoma
por: Nakamura, Tomoki, et al.
Publicado: (2016)

Prednisolone improves walking in Japanese Duchenne muscular dystrophy patients
por: Takeuchi, Fumi, et al.
Publicado: (2013)

Diagnosis and treatment of bone metastasis: comprehensive guideline of the Japanese Society of Medical Oncology, Japanese Orthopedic Association, Japanese Urological Association, and Japanese Society for Radiation Oncology
por: Shibata, H, et al.
Publicado: (2016)

Recommendations for long-term outcomes in sepsis and septic shock: a comparison between Japanese and international guidelines
por: Kawai, Yusuke, et al.
Publicado: (2022)

Establishment of a novel clear cell sarcoma cell line (Hewga-CCS), and investigation of the antitumor effects of pazopanib on Hewga-CCS
por: Outani, Hidetatsu, et al.
Publicado: (2014)

Assessing archetypes of organizational culture based on the Competing Values Framework: the experimental use of the framework in Japanese neonatal intensive care units
por: Sasaki, Hatoko, et al.
Publicado: (2017)

High prevalence of fragmented QRS on electrocardiography in Japanese patients with diabetes irrespective of metabolic syndrome
por: Yagi, Kunimasa, et al.
Publicado: (2021)

Developing Artificial Intelligence Models for Extracting Oncologic Outcomes from Japanese Electronic Health Records
por: Araki, Kenji, et al.
Publicado: (2022)

Assessing doctors’ competencies using multisource feedback: validating a Japanese version of the Sheffield Peer Review Assessment Tool (SPRAT)
por: Sasaki, Hatoko, et al.
Publicado: (2015)

Development of the Japanese version of the Minneapolis-Manchester Quality of Life Survey of Health - Adolescent Form (MMQL-AF) and investigation of its reliability and validity
por: Koike, Makiko, et al.
Publicado: (2014)

Clinical Outcome of Low-Grade Myofibroblastic Sarcoma in Japan: A Multicenter Study from the Japanese Musculoskeletal Oncology Group
por: Kito, Munehisa, et al.
Publicado: (2023)

Clinical characteristics of hoarding disorder in Japanese patients
por: Kuwano, Masumi, et al.
Publicado: (2020)

Marine Biodiversity in Japanese Waters
por: Fujikura, Katsunori, et al.
Publicado: (2010)

Skin rash by gefitinib is a sign of favorable outcomes for patients of advanced lung adenocarcinoma in Japanese patients
por: Sugiura, Yasoo, et al.
Publicado: (2013)

Presence of myocilin sequence variants in Japanese patients with open-angle glaucoma
por: Mengkegale, MingGe, et al.
Publicado: (2008)

Predictors of Cardioembolic Stroke in Japanese Patients with Atrial Fibrillation in the Fushimi AF Registry
por: Yasuda, Ken, et al.
Publicado: (2018)

CARBOPLATIN DOSING FOR ADULT JAPANESE PATIENTS
por: ANDO, YUICHI, et al.
Publicado: (2014)

The First Pilot Genome-Wide Gene-Environment Study of Depression in the Japanese Population
por: Otowa, Takeshi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_56n769q0kjeo7j33bdc08rtcc4